Evoke Pharma, Inc.
Evoke Pharma, Inc. (EVOK) is a Drug manufacturers specialty generic company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Evoke Pharma, Inc. in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
- Sector
- Healthcare
- Industry
- Drug manufacturers specialty generic
- Country
- United States
- Exchange
- Nasdaq
- CEO
- Mark A. Kowieski
- Employees
- 3
- IPO date
- 25 Sep 2013
- ISIN
- US30049G3020
- Website
- evokepharma.com
Frequently asked questions
Where is Evoke Pharma, Inc. stock listed?
Evoke Pharma, Inc. (EVOK) is listed on Nasdaq.